Johnson & Johnson Named a 2020 Fortune World’s Most Admired Company
COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate AnsweredDid you like reading this story? Click the heart to show your love.
The COVID-19 Data Plan: 3 Innovative Ways Johnson & Johnson Is Using Data Science to Fight the PandemicDid you like reading this story? Click the heart to show your love.
A Message from Chairman and CEO Alex Gorsky About Johnson & Johnson's Investigational COVID-19 Vaccine CandidateDid you like reading this message? Click the heart to show your love.
For the 18th year, Johnson & Johnson has been named to Fortune’s list of the World’s Most Admired Companies. Johnson & Johnson also placed #1 in the Pharmaceutical category worldwide for the seventh consecutive year.
To compile the international list, Fortune magazine partners with consulting firm Korn Ferry to survey industry analysts, as well as top executives and directors from Fortune 1000, Global 500 and other major non-U.S. companies. Their remit: identify companies with the strongest reputations based on a mix of nine attributes, including innovativeness, social responsibility to the community and the ability to attract and retain talented people.
In 2019, to help combat the world's second worst outbreak of Ebola on record, the company committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to the Democratic Republic of the Congo.ShareDid you like reading this story? Click the heart to show your love.
A Year of Groundbreaking Work From a World's Most Admired Company
One of the key tenets in Johnson & Johnson's guiding mission statement, Our Credo, is a responsibility to be a consistent positive force as it helps tackle some of the world's most pressing unmet healthcare needs.
The company marked many positive milestones in this regard in 2019, including the U.S. Food and Drug Administration (FDA) approval of a treatment from the Janssen Pharmaceutical Companies of Johnson & Johnson that may help provide more hope for some patients living with metastatic urothelial cancer.
Johnson & Johnson also made a commitment to donate up to 500,000 doses of an investigational Janssen vaccine regimen to the Democratic Republic of the Congo to help combat the world's second worst outbreak of Ebola on record. In 2019, it also launched the Mosaico trial at approximately 55 clinical trial sites across North America, South America and Europe to evaluate a mosaic-based vaccine concept for HIV prevention.
The company culture of innovation isn't just limited to scientific research and development either. After appearing on its list for more than three decades, Johnson & Johnson nabbed the #1 spot on Working Mother's 100 Best Companies List in 2019 for its vast variety of forward-thinking family benefits, from generous parental leave for moms and dads to backup dependent care support.
Johnson & Johnson is always striving to help improve the trajectory of health for humanity—and the company is proud to be recognized for this work by being named a World's Most Admired Company.